Medication monitoring and optimization: A targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence

Journal of Managed Care Pharmacy

Volumn 20, Issue 8, 2014, Pages 786-792

  van Boven, Job F M ^a   Stuurman Bieze, Ada G G ^d   Hiddink, Eric G ^a,b,c   Postma, Maarten J ^a   Vegter, Stefan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Stichting Health Base   (Netherlands)

^c PharmaPartners   (Netherlands)

^d Department of Clinical Decision Support   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; GENERIC DRUG;

ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG MONITORING; HEALTH PROGRAM; HUMAN; MEDICATION COMPLIANCE; MEDICATION MONITORING AND OPTIMIZATION PROGRAM; OSTEOPOROSIS; PATIENT COUNSELING; PATIENT SATISFACTION; PHARMACIST; PHARMACY; PRIMARY PREVENTION; PUBLICATION; QUALITY OF LIFE; SECONDARY PREVENTION; CHRONIC DISEASE; COST BENEFIT ANALYSIS; PATIENT COMPLIANCE; PROCEDURES; ALGORITHM; DATA BASE; DRUG COST; HIGH RISK PATIENT; MEDICATION THERAPY MANAGEMENT; NETHERLANDS; PATIENT CARE; PHARMACEUTICAL CARE; PRESCRIPTION; SOFTWARE;

CHRONIC DISEASE; COMMUNITY PHARMACY SERVICES; COST-BENEFIT ANALYSIS; DRUG MONITORING; HUMANS; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACISTS;

EID: 84904859368     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.8.786     Document Type: Article

References (32)

1. Hiligsmann M, Rabenda V, Bruyère O, Reginster JY. The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients. Health Policy. 2010;96(2):170-77.
2. Murphy AC, Proeschal A, Brightling CE, et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax. 2012;67(8):751-53.
3. van Boven JF, Chavannes NH, van der Molen T, Rutten-van Mölken MP, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med. 2014;108(1):103-13.
4. Mayor S. Non-adherence to medication increases stroke risk in patients with high blood pressure. BMJ. 2013;347:f4586.
5. García-Cárdenas V, Sabater-Hernández D, Kenny P, Martínez-Martínez F, Faus MJ, Benrimoj SI. Effect of a pharmacist intervention on asthma control:a cluster randomised trial. Respir Med. 2013;107(9):1346-55.
6. Tommelein E, Mehuys E, van Hees T, et al. Effectiveness of pharmaceutical care for patients with chronic obstrutive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol. 2014;77(5):756-66.
7. van Boven JF, Hiddink EG, Stuurman-Bieze AG, Schuiling-Veninga CC, Postma MJ, Vegter S. The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma. Int J Clin Pharm. 2013;35(6):1075-82.
8. Stuurman-Bieze AG, van den Berg PB, Tromp TF, de Jong-van den Berg LT. Computer-assisted medication review for asthmatic patients as a basis for intervention: constructing and validating an algorithmic computer instrument in pharmacy practice. Pharm World Sci. 2004;26(5):289-96.
9. Stuurman-Bieze AG, Hiddink EG. Pharmaceutical care interventions, initiated by computerized drug prescription monitoring, improve drug compliance [article in Dutch]. Pharmaceutisch Weekblad-Wetenschappelijk Platform. 2010;4(7):128-35.
10. van Boven JF, Hiddink EG, Stuurman-Bieze AG, Postma MJ, Vegter S. Structured medication surveillance for improving adherence to bisphosphonate therapy offers perspectives for cost-effective pharmaceutical care [article in Dutch]. Pharmaceutisch Weekblad-Wetenschappelijk Platform. 2011;5(9):147-53.
11. van Boven JF, Oosterhof P, Hiddink EG, Stuurman-Bieze AG, Postma MJ, Vegter S. Cost-effectiveness of increasing bisphosphonates adherence for osteoporosis in community pharmacies. Value Health. 2011;14(7):A310/PMS42.
12. Stuurman-Bieze AG, Hiddink EG, van Boven JF, Vegter S. Proactive pharmaceutical care interventions improve patients' adherence to lipidlowering medication. Ann Pharmacother. 2013;47(11):1448-56.
13. Vegter S, Oosterhof P, van Boven JF, Stuurman-Bieze AG, Hiddink EG, Postma MJ. Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis. J Manag Care Pharm. 2014;20(7):722-32.Available at: http://www.amcp.org/WorkArea/ DownloadAsset.aspx?id=18261.
14. Leufkens HGM, Urquhart J. Automated pharmacy record linkage in the Netherlands. In: Strom BL, ed. Pharmacoepidemiology. Chichester, UK: John Wiley and Sons; 2008:347-60.
15. van Boven JF, de Boer PT, Postma MJ, Vegter S. Persistence with osteoporosis medication among newly-treated osteoporotic patients. J Bone Miner Metab. 2013;31(5):562-70.
16. Vegter S, Nguyen NH, Visser ST, de Jong-van den Berg LT, Postma MJ, Boersma C. Compliance, persistence, and switching patterns for ACE inhibitors and ARBs. Am J Manag Care. 2011;17(9):609-16.
17. de Gier JJ. The Electronic Pharmaceutical Dossier: an effective aid to documenting pharmaceutical care data. Pharm World Sci. 1996;18(6):241-43.
18. Osborne ML, Vollmer WM, Johnson RE, Buist AS. Use of an automated prescription database to identify individuals with asthma. J Clin Epidemiol. 1995;48(11):1393-97.
19. Pont LG, van der Werf GT, Denig P, Haaijer-Ruskamp FM. Identifying general practice patients diagnosed with asthma and their exacerbation episodes from prescribing data. Eur J Clin Pharmacol. 2002;57(11):819-25.
20. Juniper EF, Bousquet J, Abetz L, Bateman ED, and the GOAL Committee. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006;100(4):616-21.
21. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
22. Stuurman-Bieze AG, Hiddink EG, van Boven JF, Vegter S. Proactive pharmaceutical care interventions decrease patients' non-adherence to osteoporosis medication. Osteoporos Int. 2014;25(6):1807-12.
23. van Boven JF, Stuurman-Bieze AG, Hiddink EG, Postma MJ, Vegter S. Effects of targeted pharmaceutical care in patients with asthma and COPD: results of a pilot study [article in Dutch]. Pharmaceutisch Weekblad-Wetenschappelijk Platform. 2014(8):a1413.
24. Stuurman-Bieze AG, Kokenberg ME, Tobi H, et al. Complex pharmaceutical care intervention in pulmonary care: part B. Patient opinion and process survey. Pharm World Sci. 2005;27(5):385-92.
25. van den Boogaard CH, Breekveldt-Postma NS, Borggreve SE, Goettsch WG, Herings RM. Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study. Curr Med Res Opin. 2006;22(9):1757-64.
26. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333(20):1301-07.
27. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals:a randomised placebo-controlled trial. Lancet. 2002;360(9326):7-22.
28. Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549-59.
29. Boonen LH, van der Geest SA, Schut FT, Varkevisser M. Pharmaceutical policy in the Netherlands: from price regulation towards managed competition. Adv Health Econ Health Serv Res. 2010;22:53-76.
30. Boland MR, van Boven JF, Rutten-van Mölken MP. Mapping the CCQ onto EQ-5D scores (im)possible? Value Health. 2013;16(7):A329-30.
31. Vegter S, van Boven JF, Hiddink EG, Postma MJ. [Health economic evaluation of pharmaceutical patient care interventions]. In: Gier H, Bouvy M, De Smet P, eds. Handboek farmaceutische patiëntenzorg [Pharmaceutical Patient Care]. Houten, Netherlands: Prelum Uitgevers; 2013.
32. De Bruin M, Hospers HJ, van Breukelen GJ, Kok G, Koevoets WM, Prins JM. Electronic monitoring-based counseling to enhance adherence among HIV-infected patients: a randomized controlled trial. Health Psychol. 2010;29(4):421-28.